Loading…

READY TO ROCK?

Click the button below to start exploring our website and learn more about our awesome company
Start exploring

Images were acquired using Openlab software

Images were acquired using Openlab software. == Viral growth analysis == Human osteosarcoma cells, 143B, were added to six-well plates at a concentration of 8 105per well and incubated overnight at 37C in DMEM containing 5% FBS. Consistently, ATG3 was shown to be required for the vaccinia virus induced LC3 lipidation. Strikingly, despite the high levels of LC3 lipidation, subsequent electron microscopy showed that vaccinia virus-infected cells were devoid of autophagosomes, either in normal growth medium or upon serum and amino acid deprivation. In addition, no autophagy flux was observed in virus-infected cells. We further demonstrated that neither ATG3 nor LC3 Epoxomicin lipidation is crucial for viral membrane biogenesis or viral proliferation and infection. Together, these results indicated that vaccinia virus does not exploit the cellular autophagic membrane biogenesis machinery for their viral membrane production. Moreover, this study demonstrated that vaccinia virus instead actively disrupts the cellular autophagy through a novel molecular mechanism that is associated with aberrant LC3 lipidation and a direct conjugation between ATG12 and ATG3. Keywords:ATG12, ATG3, autophagy, LC3 lipidation, vaccinia virus == Introduction == Vaccinia virus is a member of the Orthopoxvirus genus of the family Poxviridae. It is the most well-studied poxvirus and has been successfully implemented as a vaccine to eradicate variola virus, the causative agent of smallpox disease. A unique feature of vaccinia and all poxviruses is that the life cycle is exclusively cytosolic. The morphogenesis of the large, complex, enveloped virus involves several distinct forms of virion.1The life cycle of the virus begins in sequestered subcellular regions of the infected host cell, referred to as virus factories, and is the location where crescent membranes develop and surround dense viroplasm to form spherical immature virus (IV).2These Epoxomicin crescent membranes, containing lipid and protein, are the first visible membrane structures in the host cell post-infection which enclose the core components of Epoxomicin the virus and are reported to contain a double-membrane structure.3In addition, vaccinia requires the procurement of an additional membrane allowing for the nonlytic escape of viral particles from the host cell. The source of the membranes that arise to form the IVs are still controversial despite being intensely scrutinized over the past several decades. Epoxomicin It has been suggested that the crescent membranes are not host derived but are instead formed by a de novo synthesis process,4while opposing researchers have proposed an alternative double-membrane model and argue the membrane originates from the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) of the host cell.3,5,6 Macroautophagy, hereafter Rabbit Polyclonal to NOTCH4 (Cleaved-Val1432) referred to as autophagy, is a membrane-trafficking pathway leading to lysosomal degradation of cytosolic components.7-10The hallmark of this pathway involves the generation of autophagosomes, which are double-membrane structures9-11that sequester the cytosol and its constituents and deliver them to the lysosome for degradation. In parallel with the controversy surrounding the crescent membranes of vaccinia, the origin of the double-membrane phagophore assembly sites are also highly debated. The purported concept of de novo synthesis for the crescent membranes which mature to become autophagosomes has been proposed. More recent studies have suggested that the source of the membranes could also be derived from pre-existing organelles, such as the endoplasmic reticulum,12mitochondria,13plasma membrane14or Golgi network.15 The autophagic pathway requires two interlinked ubiquitin-like protein conjugation systems.16-18In one system, the C-terminal glycine of a ubiquitin-like protein ATG12 is conjugated to a lysine residue of ATG516via an isopeptide bond which is catalyzed by ATG7, an E1 equivalent enzyme19and ATG10, an E2 equivalent enzyme.20In the other system, ATG8 or, in mammals, MAP-LC3 (microtubule-associated protein 1 light chain 3), is cleaved.